Australian & New Zealand Childrens Haematology/Oncology Group

Clinical Trials

PRISM: PRecISion Medicine for Children with Cancer

High-risk cancers

Status: Open | NSW , QLD , TAS , VIC , WA , SA

This study aims to see if a personalised approach can be used to find treatment options for children with high-risk cancer by analysing each child’s cancer using a range of different models. Also, the study seeks to understand the psychological impact of participation in a personalised cancer medicine study, and to analyse the costs and benefits of the personalised approach to manage high-risk cancers. Researchers will also be examining whether there are heritable genetic variants that increase the risk of developing cancer at a young age.

Disease Stage: Initial diagnosis/relapse

Patient Age Range: <21 years

Sample Size: Approximately 250

Trial Sponsors:

  • National: ANZCHOG